Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

BioSante Pharmaceuticals, Inc. (BPAX)

-NasdaqGM

1.14 Down 0.01(0.87%) 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 145   1,968   110   109  
Cost of Revenue -  95   -   -  
Gross Profit 145   1,873   110   109  
Operating Expenses
Research Development972  2,435  3,873  5,398  
Selling General and Administrative1,949  2,902  1,547  1,949  
Non Recurring -   -   -   -  
Others166  171  26  31  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,943) (3,635) (5,335) (7,269)
Income from Continuing Operations
Total Other Income/Expenses Net717  (287)(842)17  
Earnings Before Interest And Taxes(2,226)(3,923)(6,177)(7,252)
Interest Expense65  65  67  92  
Income Before Tax(2,291)(3,987)(6,244)(7,344)
Income Tax Expense -   -  (122) -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,291)(3,987)(6,122)(7,344)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,291) (3,987) (6,122) (7,344)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,291) (3,987) (6,122) (7,344)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.